How Asthma Affects Communities Across the Country
Asthma does not look the same in every state or every household. According to CDC data, the proportion of adults with current asthma who still experience symptoms despite being diagnosed varies notably by region—Indiana reports some of the highest rates, while California sits at the lower end. These differences reflect a mix of environmental triggers, access to specialty care, and local air quality conditions that make asthma management a distinctly regional challenge.
What ties these experiences together is a shared frustration: many people follow their prescribed regimen—daily controller inhalers, rescue medications, trigger avoidance—yet still find themselves in emergency rooms or canceling plans because their lungs will not cooperate. Industry estimates suggest that roughly 5 to 10 percent of people with asthma have a form that does not respond well to standard inhaled therapies. For these individuals, the search for better options is not academic; it is urgent.
Recent developments in asthma research have shifted attention toward biologic therapies—medications that target specific inflammatory pathways rather than broadly suppressing the immune system. Drugs like tezepelumab, benralizumab, and the more recently approved depemokimab represent a generation of treatments designed for people whose asthma is driven by particular types of inflammation. Many of these therapies are still being studied in clinical trials across the United States, with research sites in Arizona, California, Illinois, New York, North Carolina, and beyond. The American Lung Association's Airways Clinical Research Centers, along with major institutions like UCSF, the University of Pittsburgh, and Northwestern University, run active asthma clinical trials that enroll participants year-round.
What Participating in a Trial Actually Involves
Clinical trials are not all the same, and understanding the differences can help you decide whether participation makes sense. Some studies test entirely new medications, while others look at whether an existing drug can be used in a different way—such as reducing the frequency of dosing or combining it with another treatment. The table below outlines the main categories of asthma trials you might encounter.
| Trial Type | What Researchers Study | Typical Duration | Who Might Be a Fit |
|---|
| Phase 2 Trials | Safety and early effectiveness of a new drug | Several months to a year | People with moderate-to-severe asthma who have not responded to standard treatments |
| Phase 3 Trials | Confirming effectiveness compared to placebo or existing therapy | One to two years | Larger groups of patients across multiple locations |
| Phase 4 Trials | Long-term safety and real-world use of an already approved medication | Varies | Broader populations, including those with coexisting conditions |
| Observational Studies | Tracking outcomes without changing current treatment | Months to years | Anyone willing to share health data and undergo periodic testing |
The process of joining a trial typically begins with a screening visit. You answer questions about your medical history, current medications, and asthma triggers. If you appear to meet the initial criteria, the research team schedules a more thorough evaluation that often includes lung function tests, blood work, and a physical exam. Only after all screening results are reviewed does the team confirm whether you qualify.
One common concern is the possibility of receiving a placebo instead of the active treatment. In many asthma trials, participants continue using their standard medications alongside the study drug, which means nobody goes without care. The research team will explain exactly how the study is designed during the informed consent process, and you have the right to ask questions and withdraw at any time.
Travel and time commitment vary by study. Some trials require weekly visits to a research center; others involve monthly check-ins with phone calls in between. The University of Pittsburgh's Asthma Institute, for example, notes that initial screening visits can run about 90 minutes, with compensation for time and travel expenses provided. Many research sites across the country offer similar arrangements, though the specifics depend on the study sponsor and the phase of research.
Real Stories Behind the Research
Consider someone like Emma, a nurse in her thirties who had lived with severe asthma since adolescence. At her worst, she was hospitalized nearly every month, including stays in intensive care. Standard treatments barely kept her symptoms at bay. When she enrolled in a clinical trial testing a twice-yearly biologic injection, she was cautiously hopeful. The results, published by the research team, showed that patients who switched to the longer-acting medication maintained the same level of asthma control as those taking injections every four to eight weeks. For someone juggling a demanding job and family responsibilities, reducing the treatment burden from twelve or more injections per year to just two can be meaningful.
Stories like this are not guarantees—every person responds differently to investigational treatments—but they illustrate why trials matter. They are not just about collecting data; they are about discovering whether a new approach can change how someone lives with a chronic condition.
For people in states with high asthma prevalence, like Indiana or Illinois, finding a nearby trial can be particularly important. The Asthma and Airway Disease Research Center at the University of Arizona in Tucson, the Northwestern Airways Disease Center in Chicago, and Mount Sinai's Respiratory Institute in New York City are a few examples of sites actively recruiting for asthma studies. Searching "asthma research studies near me" or browsing the American Lung Association's clinical trial listings can surface options that might not appear through a general web search.
How to Take the Next Step
If you are considering a clinical trial, start by talking with your pulmonologist or primary care provider. They can help you assess whether your current treatment is truly optimized and whether a trial might complement—not replace—your existing care plan. Bring a list of questions to that conversation: What phase is the trial? What is known about the drug so far? How often will I need to visit the research site? What happens when the study ends?
From there, you can explore listings on ClinicalTrials.gov, which allows you to filter by condition, location, and study phase. The American Lung Association also maintains a searchable directory of trials at its Airways Clinical Research Centers. When you find a study that seems relevant, contact the research coordinator directly. They will walk you through the eligibility criteria and explain what participation involves in practical terms.
Keep in mind that eligibility requirements can be specific. Some trials enroll only people with moderate-to-severe uncontrolled asthma who have experienced a recent exacerbation requiring oral steroids. Others focus on patients with elevated eosinophil levels or those with a particular body mass index. These criteria exist to ensure the study produces meaningful results, not to discourage participation. If you do not qualify for one trial, another may be a better fit.
The decision to join a clinical trial is personal. It involves weighing the possibility of accessing a promising treatment before it becomes widely available against the uncertainty inherent in any research study. The close monitoring that comes with trial participation—regular lung function tests, detailed symptom tracking, direct access to specialists—can also appeal to people who want a deeper understanding of their condition, regardless of the study's outcome.
研究の知恵